BRIEF-Tilray Brands Inc - Enters Agreement To Buy Brewdog's Key U.S. Assets-March 2024-www.financetom.com

BRIEF-Tilray Brands Inc - Enters Agreement To Buy Brewdog's Key U.S. Assets

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Tilray Brands Inc - Enters Agreement To Buy Brewdog's Key U.S. Assets

Mar 16, 2026 5:34 AM

March 16 (Reuters) - Tilray Brands Inc ( TLRY ):

* TILRAY BRANDS INC ( TLRY ) - ENTERS AGREEMENT TO BUY BREWDOG'S KEY

U.S. ASSETS

* TILRAY BRANDS INC ( TLRY ) - TO BUY BREWDOG'S U.S. BREWERY, PUBS,

HOTEL, LAS VEGAS BREWPUB, DENVER FRANCHISE, AIRPORT LICENSE

Source text:

Further company coverage:

;))

Previous page： Rio Tinto Q4 Iron Ore Shipments Decline, Bauxite Output Rises From Australia Next page： Silexion Shares Rise Late Following Pretrial Data From Pancreatic Cancer Treatment Showing Efficacy

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Rio Tinto Q4 Iron Ore Shipments Decline, Bauxite Output Rises From Australia

Jan 15, 2025

05:22 PM EST, 01/15/2025 (MT Newswires) -- Rio Tinto (RIO) reported Q4 iron ore shipments from the Pilbara region in Australia fell 1% to 85.7 million metric tons from a year earlier. Bauxite production from the Amrun and Gove mines in Australia increased 2% to 15.4 million tons, the company said Wednesday in a statement. ...

Silexion Shares Rise Late Following Pretrial Data From Pancreatic Cancer Treatment Showing Efficacy

Jan 15, 2025

05:23 PM EST, 01/15/2025 (MT Newswires) -- Silexion Therapeutics ( SLXN ) was 74% higher in Wednesday's after-hours session, after it disclosed preclinical data demonstrated the synergistic efficacy of its SIL-204 candidate to treat certain form of pancreatic cancer. The data show that SIL-204 worked well in combination with the primary components of two chemotherapies, 5-fluorouracil and irinotecan, in human...

Alphabet CEO to join tech leaders at Trump inauguration

Jan 15, 2025

(Reuters) - Alphabet CEO Sundar Pichai is among the Big Tech leaders planning to attend U.S. President-elect Donald Trump's inauguration on Monday, a person familiar with the matter told Reuters on Wednesday. Apple's ( AAPL ) Tim Cook will also be attending the event, Bloomberg News reported earlier in the day. Tech CEOs Elon Musk, Jeff Bezos and Mark Zuckerberg...

Opko Health Insider Bought Shares Worth $740,850, According to a Recent SEC Filing

Jan 15, 2025

05:22 PM EST, 01/15/2025 (MT Newswires) -- Phillip Frost, 10% Owner, Director, CEO & Chairman, on January 15, 2025, executed a purchase for 500,000 shares in Opko Health ( OPK ) for $740,850. Following the Form 4 filing with the SEC, Frost has control over a total of 246,732,605 shares of the company, with 3,568,951 shares held directly and 243,163,654...